These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2713215)

  • 1. Bayesian derived predictions for twice daily theophylline under outpatient conditions and an assessment of optimal sampling times.
    Chrystyn H; Ellis JW; Mulley BA; Peake MD
    Br J Clin Pharmacol; 1989 Feb; 27(2):215-21. PubMed ID: 2713215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The accuracy of a pharmacokinetic theophylline predictor using once daily dosing.
    Chrystyn H; Mulley BA; Peake MD
    Br J Clin Pharmacol; 1987 Sep; 24(3):301-7. PubMed ID: 3663446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a novel Bayesian method for individualizing theophylline dosage.
    Stein U; Oellerich M; Sybrecht GW; Schneider B
    J Clin Chem Clin Biochem; 1988 Jun; 26(6):405-14. PubMed ID: 3411295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The accuracy and stability of Bayesian theophylline predictions.
    Chrystyn H; Ellis JW; Mulley BA; Peake MD
    Ther Drug Monit; 1988; 10(3):299-305. PubMed ID: 3176107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Individualization of theophylline dosage: a Bayesian method evaluated in patients with once-daily dosing.
    Martz W; Oellerich M; Schnabel D; Sybrecht GW
    Ther Drug Monit; 1991 Sep; 13(5):420-4. PubMed ID: 1957334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Steady state pharmacokinetics, metabolism and pharmacodynamics of theophylline in children after unequal twice-daily dosing of a new sustained-release formulation.
    Reinhardt D; Berdel D; Heimann G; Kusenbach G; von Berg A; Johnson E; Steinijans VW; Staudinger H
    Chronobiol Int; 1987; 4(3):369-80. PubMed ID: 3677217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of morning or evening administration on absorption of theophylline.
    Su YM; Cheng TP; Yeh TW; Wen CY; Wang DI
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Feb; 63(2):113-8. PubMed ID: 10677921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Twenty-four hour lung function in adult patients with asthma. Chronoptimized theophylline therapy once-daily dosing in the evening versus conventional twice-daily dosing.
    D'Alonzo GE; Smolensky MH; Feldman S; Gianotti LA; Emerson MB; Staudinger H; Steinijans VW
    Am Rev Respir Dis; 1990 Jul; 142(1):84-90. PubMed ID: 2195936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative pharmacokinetics of morning and evening doses of once-a-day theophylline capsules.
    Harrison LI; Kehe CR; Ekholm BP; Chang SF; Lavoie KA; Kisicki JC
    J Pharm Sci; 1994 Aug; 83(8):1171-4. PubMed ID: 7983603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioavailability of a slow-release theophylline capsule given twice daily to preschool children with chronic asthma: comparison with liquid theophylline.
    Sallent J; Hill M; Stecenko A; McKenzie M; Hendeles L
    Pediatrics; 1988 Jan; 81(1):116-20. PubMed ID: 3336577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of once-daily theophylline dose following the morning versus evening administration.
    Trnavská Z; Vondra V; Elis J
    Arzneimittelforschung; 1989 Sep; 39(9):1149-51. PubMed ID: 2590267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic comparison of a once-daily and twice-daily theophylline delivery system.
    González MA; Kisicki J; Straughn AB
    Clin Ther; 1994; 16(4):686-92. PubMed ID: 7982257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A single oral dose method for predicting steady state theophylline concentrations in clinical practice.
    Mann JS; Fitzpatrick RW; Jones PW; Prowse K; Mucklow JC; Cole RB
    Respir Med; 1990 Nov; 84(6):479-84. PubMed ID: 2274687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Once-daily dosing of a new ultrasustained-release theophylline preparation.
    Van den Brande P; Nys J; Tjandramaga TB; Verhelst F; Demedts M
    Respiration; 1987; 52(2):144-53. PubMed ID: 3671893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The design of oral sustained-release theophylline dosing after conversion from intravenous to oral therapy.
    Yamazaki M; Fukutomi O; Kondo N; Kato Z; Nakashima Y; Shinoda S; Agata H; Kondo T; Imaeda N; Orii T
    Int J Clin Pharmacol Ther; 1994 Nov; 32(11):625-31. PubMed ID: 7874380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Steady-state pharmacokinetics of a once-daily theophylline formulation (Euphylong) when given twice daily.
    Götz J; Sauter R; Steinijans VW; Jonkman JH
    Int J Clin Pharmacol Ther; 1994 Apr; 32(4):168-73. PubMed ID: 8032575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of sustained release theophylline given at three different evening intake times in addition to a baseline medication.
    Siebert B; Kunkel G; Borner K; Staudinger HW; Steinijans VW
    Eur Respir J; 1990 Feb; 3(2):176-81. PubMed ID: 2178965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biopharmaceutic characteristics of a new extended-release theophylline formulation (Uni-Dur).
    Oosterhuis B; Brannan MD; Groen H; Peeters PA; Hempenius J; Radwanski E; Nomeir AA; Affrime MB; Jonkman JH
    Ann Allergy Asthma Immunol; 1995 Aug; 75(2):157-61. PubMed ID: 7648380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of dosing time on the pharmacokinetics and pharmacodynamics of a 'once-a-day' sustained release theophylline preparation.
    Lamont H; Pauwels R; Van der Straeten M
    Br J Clin Pharmacol; 1987 Dec; 24(6):735-42. PubMed ID: 3440095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of three theophylline dosing methods in pediatric patients.
    Godley PJ; Karboski JA; Godley SE; Edwards GA; Moore ES; Sagraves R
    DICP; 1991 Feb; 25(2):179-85. PubMed ID: 2058190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.